Beers, STOPP/START, and PRISCUS: A critical analysis of their evolution and applicability in geriatrics prescribing.

Publication date

2026-01-13T09:45:47Z

2026-01-13T09:45:47Z

2025-03-18

2026-01-13T09:45:47Z



Abstract

Introduction: Polypharmacy, defined as the concomitant use of five or more medications, is common in older adults. Potentially inappropriate medications (PIMs) are drugs whose risks outweigh their potential benefits in older adults, especially when other effective alternatives are available. The objective of this research is to conduct a comparative analysis of the evolution, cross-cultural adaptations, advantages, and limitations of the Beers, STOPP/START, and PRISCUS criteria to evaluate their applicability in diverse clinical contexts.Method: A critical narrative review of articles retrieved from the PubMed, LILACS, SciELO, and Cochrane databases. The search was limited to the period between 2014 and 2024, with no initial language restrictions applied. Original articles, systematic reviews, clinical practice guidelines, and validation studies were included.Results: Out of the 675 references retrieved, 31 articles were selected after applying the inclusion and exclusion criteria. The Beers criteria accounted for 73.7 % of the total identified publications (n=498/675), and the 11 adaptations of the STOPP/START criteria were noteworthy.Conclusions: The Beers and STOPP/START criteria have transcended their original purpose to become foundational pillars for the development of local tools. Their value lies not only in their direct application but also in their role as reference frameworks for the creation and validation of culturally adapted criteria.

Document Type

Article


Published version

Language

Spanish

Publisher

Universidad de Granada

Related items

Reproducció del document publicat a: https://doi.org/10.30827/ars.v67i1.34825

Ars Pharmaceutica, 2025, vol. 67, num.1, p. 113-125

https://doi.org/10.30827/ars.v67i1.34825

Recommended citation

This citation was generated automatically.

Rights

cc-by-nc-nd (c) Alemán-Fernández E et al., 2025

http://creativecommons.org/licenses/by-nc-nd/4.0/